Current and future trials with zidovudine
- 1 January 1989
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 18, 93-96
- https://doi.org/10.1016/s0163-4453(89)80088-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patientsJournal of Infection, 1989
- Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experienceJournal of Infection, 1989
- Preliminary report of a multicentre study of zidovudine plus or minus acyclovir in patients with acquired immune deficiency syndrome or acquired immune deficiency syndrome-related complexJournal of Infection, 1989
- Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex with a Regimen of 3′-Azido-2′,3′-Dideoxythymidine (Azidothymidine or Zidovudine) and AcyclovirAnnals of Internal Medicine, 1988
- PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)The Lancet, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987